Surve, D. H., Jirwankar, Y. B., Dighe, V. D., & Jindal, A. B. (2020). Long-Acting Efavirenz and HIV-1 Fusion Inhibitor Peptide Co-loaded Polymer-Lipid Hybrid Nanoparticles: Statistical Optimization, Cellular Uptake, and In Vivo Biodistribution. Molecular pharmaceutics, 17(10), 3990. https://doi.org/10.1021/acs.molpharmaceut.0c00773
Citace podle Chicago (17th ed.)Surve, Dhanashree H., Yugandhara B. Jirwankar, Vikas D. Dighe, a Anil B. Jindal. "Long-Acting Efavirenz and HIV-1 Fusion Inhibitor Peptide Co-loaded Polymer-Lipid Hybrid Nanoparticles: Statistical Optimization, Cellular Uptake, and In Vivo Biodistribution." Molecular Pharmaceutics 17, no. 10 (2020): 3990. https://doi.org/10.1021/acs.molpharmaceut.0c00773.
Citace podle MLA (9th ed.)Surve, Dhanashree H., et al. "Long-Acting Efavirenz and HIV-1 Fusion Inhibitor Peptide Co-loaded Polymer-Lipid Hybrid Nanoparticles: Statistical Optimization, Cellular Uptake, and In Vivo Biodistribution." Molecular Pharmaceutics, vol. 17, no. 10, 2020, p. 3990, https://doi.org/10.1021/acs.molpharmaceut.0c00773.